This site is intended for healthcare professionals only
Bowel Cancer UK is the UK’s leading bowel cancer charity, determined to save lives and improve the quality of life of everyone affected by bowel cancer. We work with health professionals across the UK to improve the treatment, care and support for people affected by bowel cancer. We provide educational opportunities and health information to support you and your patients.
Resources
Cancer Care Review
This resource has been developed, organised and funded by Boehringer Ingelheim. The content has been reviewed and approved by the sponsoring company prior to the symposium. Editorial support for this symposium has been provided by OmniaMed Communications.
Prostate Cancer UK’s top priority is funding research to stop prostate cancer killing men. We’re investing millions to find better treatments and better tests that can spot fast-growing cancers early, and could be used in a screening programme to save thousands of lives.
We were the first national organisation for prostate cancer in the UK. Our aim was to improve the care and welfare of those affected by prostate cancer, increase investment in research, and raise public and political awareness of a long-neglected disease. In the last 20 years, we’ve invested over £37 million into ground breaking research, and continue to provide award-winning support for men.
We have grown in size, strength and influence but our ambition is the same: to put men at the heart of everything we do.
Resources
Prostate Cancer Specialist course
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Prostate Cancer Risk Management Programme and Prostate Cancer UK’s Consensus Statements on PSA testing
Chronic prostatitis and chronic pelvic pain syndrome: a consensus guideline
This quick reference guide contains priorities for implementation and a treatment algorithm.
PSA Consensus Statements
Our PSA consensus statements represent the consensus view of hundreds of health professionals, to support primary health care professionals to use the PSA test more effectively for men without symptoms of prostate cancer.
PCRMP & Prostate Cancer UK Consensus statements
Summary leaflet of Public Heath England’s Prostate Cancer Risk Management Programme guidance (2016) and Prostate Cancer UK’s ‘Consensus statements on PSA testing in asymptomatic men in the UK’ (2016) for GPs.
Resources
Male Urology in Primary Care Course
Our Male Urology in Primary Care online learning course provides practical and bitesize modules to support you when treating patients with benign disease and prostate cancer. You can complete the course at your own pace, and it’s a chance to earn CPD.
Treating erectile dysfunction after surgery for pelvic cancers and after radical radiotherapy and androgen deprivation therapy (ADT) for prostate cancer
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
PCRMP & Prostate Cancer UK Consensus statements
Summary leaflet of Public Heath England’s Prostate Cancer Risk Management Programme guidance (2016) and Prostate Cancer UK’s ‘Consensus statements on PSA testing in asymptomatic men in the UK’ (2016) for GPs.
Chronic prostatitis and chronic pelvic pain syndrome: a consensus guideline
This quick reference guide contains priorities for implementation and a treatment algorithm.
PSA Consensus Statements
Our PSA consensus statements represent the consensus view of hundreds of health professionals, to support primary health care professionals to use the PSA test more effectively for men without symptoms of prostate cancer.
PCRMP & Prostate Cancer UK Consensus statements
Summary leaflet of Public Heath England’s Prostate Cancer Risk Management Programme guidance (2016) and Prostate Cancer UK’s ‘Consensus statements on PSA testing in asymptomatic men in the UK’ (2016) for GPs.
